Diamond Biofund Inc. (TPE:6901)
Taiwan · Delayed Price · Currency is TWD 14.25
+0.25 (1.79%)
Apr 2, 2026, 1:30 PM CST
Diamond Biofund Revenue
In the year 2025, Diamond Biofund had annual revenue of -1.07B TWD. Diamond Biofund had revenue of 16.46M in the quarter ending December 31, 2025.
Revenue
-1.07B
Revenue Growth
n/a
P/S Ratio
-11.32
Revenue / Employee
-32.52M
Employees
33
Market Cap
12.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | -1.07B | 1.16B | - |
| Dec 31, 2024 | -2.23B | 210.73M | - |
| Dec 31, 2023 | -2.44B | -3.46B | - |
| Dec 31, 2022 | 1.02B | -2.05B | -66.85% |
| Dec 31, 2021 | 3.06B | -3.44B | -52.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cathay Financial Holding | 1.15T |
| Fubon Financial Holding | 970.34B |
| CTBC Financial Holding | 569.64B |
| Mercuries & Associates Holding | 160.02B |
| Yuanta Financial Holding | 136.55B |
| China Man-Made Fiber | 43.71B |
| Taiwan Fire & Marine Insurance | 7.36B |
| Concord Securities | 3.68B |